Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.8 USD | +0.66% | +8.11% | 0.00% |
Apr. 30 | HC Wainwright Initiates ArriVent BioPharma With Buy Rating, $25 Price Target | MT |
Apr. 22 | ArriVent BioPharma, Inc. Appoints Kristine Peterson to Its Board of Directors | CI |
Chart calendar ArriVent BioPharma, Inc.
Upcoming events on ArriVent BioPharma, Inc.
No events available
Past events on ArriVent BioPharma, Inc.
2024-04-04 | American Association for Cancer Research Meeting |
2024-03-28 04:05 pm | Q4 2023 Earnings Release |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 -2,50 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -73,3 - | -80,4 |
EBIT Million USD | Released Forecast Spread | 0,00 | -74,6 -67,6 -10.39% | -102 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,3 -61,3 -13.18% | -80,6 |
Net income Million USD | Released Forecast Spread | -36,9 | -69,3 -61,3 -13.18% | -80,6 |
EPS USD | Released Forecast Spread | -1,90 | -32,4 -11,3 -186.39% | -3,52 |
Announcement Date | 25/08/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
EBITDA Million USD | Released Forecast Spread | -19,2 | -19,8 | -20,4 | -21,0 | ||
EBIT Million USD | Released Forecast Spread | -24,3 | -29,2 | -22,8 | -25,4 | -24,6 | -28,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,4 | -19,5 | -20,5 | -21,0 | -25,0 | |
Net income Million USD | Released Forecast Spread | -19,4 | -19,5 | -20,5 | -21,0 | -25,0 | |
EPS USD | Released Forecast Spread | -0,94 | -0,58 | -0,61 | -0,62 | -0,73 | |
Announcement Date | - | - | - | - | - | - |
Past sector events for ArriVent BioPharma, Inc.
2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVBP Stock
- Calendar ArriVent BioPharma, Inc.